Conservative Management for Kidney Failure

Samantha Gelfand1

  • 1Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.

Insights

Conservative kidney management (CKM) offers active medical care for kidney failure without dialysis. This approach prioritizes quality of life by preserving kidney function and managing symptoms effectively.

Area of Science:

  • Nephrology
  • Geriatrics
  • Palliative Care

Background:

  • Kidney failure necessitates treatment decisions, including dialysis or conservative management.
  • Conservative kidney management (CKM) is an alternative to dialysis for end-stage renal disease.
  • CKM focuses on symptom control and quality of life.

Purpose of the Study:

  • To define Conservative Kidney Management (CKM) as an active approach to kidney failure.
  • To highlight the goals of CKM: preserving kidney function and enhancing quality of life.
  • To outline the medical management of symptoms associated with kidney failure under CKM.

Main Methods:

  • CKM involves active medical monitoring and intervention.
  • It emphasizes symptom assessment and management.
  • Preservation of remaining kidney function is a key objective.

Main Results:

  • CKM aims to optimize patients' quality of life.
  • It focuses on delaying or avoiding dialysis.
  • Effective medical management of kidney failure symptoms is achieved.

Conclusions:

  • Conservative Kidney Management is a viable option for kidney failure.
  • CKM prioritizes patient well-being and quality of life.
  • Active medical management is central to successful CKM.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
237
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
46
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
417